M. Kulyk & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Buy
22,033
+810
+4% +$100K 0.49% 45
2025
Q4
$2.67M Buy
21,223
+2,645
+14% +$345K 0.51% 46
2025
Q3
$2.72M Buy
18,578
+1,174
+7% +$177K 0.55% 45
2025
Q2
$2.71M Buy
17,404
+98
+0.6% +$15.5K 0.59% 47
2025
Q1
$2.85M Sell
17,306
-19,203
-53% -$3.19M 0.65% 45
2024
Q4
$5.95M Sell
36,509
-715
-2% -$128K 1.29% 26
2024
Q3
$7.27M Buy
37,224
+474
+1% +$87.3K 1.46% 25
2024
Q2
$6.37M Buy
36,750
+2,860
+8% +$476K 1.48% 25
2024
Q1
$5.73M Buy
33,890
+1,569
+5% +$294K 1.33% 30
2023
Q4
$6.38M Buy
32,321
+1,229
+4% +$218K 1.49% 27
2023
Q3
$5.41M Buy
31,092
+737
+2% +$134K 1.5% 24
2023
Q2
$5.23M Buy
30,355
+543
+2% +$93.9K 1.46% 27
2023
Q1
$4.96M Buy
29,812
+1,316
+5% +$216K 1.5% 28
2022
Q4
$4.18M Buy
28,496
+963
+3% +$143K 1.39% 29
2022
Q3
$4.08M Buy
27,533
+1,341
+5% +$224K 1.42% 25
2022
Q2
$4.5M Buy
26,192
+1,632
+7% +$282K 1.4% 27
2022
Q1
$4.63M Sell
24,560
-889
-3% -$176K 1.26% 32
2021
Q4
$6.21M Buy
25,449
+1,536
+6% +$336K 1.61% 21
2021
Q3
$4.64M Buy
23,913
+943
+4% +$190K 1.49% 27
2021
Q2
$4.28M Buy
22,970
+376
+2% +$65.3K 1.55% 30
2021
Q1
$3.56M Buy
22,594
+4,239
+23% +$672K 1.33% 37
2020
Q4
$3.04M Buy
+18,355
New +$2.98M 1.69% 30

Other funds holding ZTS

M. Kulyk & Associates's ZTS Position: Q1 2026 in Review

M. Kulyk & Associates increased its Zoetis (ZTS) stake by 3.8% in Q1 2026, buying an estimated $100K and bringing the position to 22,033 shares worth $2.6M. The position accounts for 0.49% of the portfolio, ranked #45.

M. Kulyk & Associates first reported a position in ZTS in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.27M in Q3 2024. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • M. Kulyk & Associates held 22,033 shares of Zoetis worth $2.6M as of Q1 2026.
  • M. Kulyk & Associates bought 810 Zoetis shares in Q1 2026, an estimated $100K.
  • Zoetis made up 0.49% of M. Kulyk & Associates's portfolio in Q1 2026, its #45 holding.
  • M. Kulyk & Associates first reported a position in Zoetis in Q4 2020 and has held it in 22 quarters since.
  • M. Kulyk & Associates's Zoetis position peaked at $7.27M in Q3 2024.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on M. Kulyk & Associates's 13F filing for Q1 2026, filed 6 May 2026.